BPCE
AGN

Bank Pictet & Cie (Europe)’s Allergan plc AGN Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,905
Closed -$337K – 160
2020
Q1 		$337K Sell
1,905
-512
-21% -$96.4K 0.03% 106
2019
Q4 		$462K Buy
+2,417
New +$436K 0.07% 108
2015
Q1 		– Sell
-900
Closed -$232K – 171
2014
Q4 		$232K Buy
+900
New +$225K 0.06% 148

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s AGN Position: Q2 2020 in Review

Bank Pictet & Cie (Europe) sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,905 shares — an estimated $337K sold.

Bank Pictet & Cie (Europe) first reported a position in AGN in Q4 2014 and held it in 3 quarters. The position peaked at $462K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Bank Pictet & Cie (Europe) reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 1,905 Allergan plc shares in Q2 2020, an estimated $337K.
  • Bank Pictet & Cie (Europe) first reported a position in Allergan plc in Q4 2014 and held it in 3 quarters.
  • Bank Pictet & Cie (Europe)'s Allergan plc position peaked at $462K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2020, filed 13 Aug 2020.